Rectal Cancer Disappears After Experimental Use of Immunotherapy
Posted:
12 patients with rectal cancer treated with dostarlimab - an anti PD1 monoclonal antibody with complete response. A very encouraging study for patients with stage 2/3 rectal cancer. More info here.
Based on research completed as part of a multi-year collaboration with Nokia Bell Labs, biomedical engineers at Duke University are developing a solution. Using a custom-built optical coherence tomography (OCT) imaging system together with artificial intelligence (AI) models grounded in…
Rare conditions in the ICU include both formally classified rare diseases and conditions that occur infrequently in critical care settings. These patients often face delayed diagnosis, limited specialist expertise and complex multisystem involvement, all of which contribute to poorer outcomes…
Attendees
Sponsors and Exhibitors
Contact us